Daniel Lee Hendricks

US Patent:

20200358925, Nov 12, 2020

Filed:

Jan 16, 2018

Appl. No.:

16/962661

Inventors:

David R. HALL - Provo UT, US
Daniel Allen - Provo UT, US
Conrad Rosenbrock - Provo UT, US
Ben Swenson - Lehi UT, US
Daniel Hendricks - Provo UT, US
Andrew Nguyen - Provo UT, US

International Classification:

H04N 1/44
H04N 7/18
H04N 5/225
A61B 5/00
A61B 5/01
A61B 1/227
A61B 1/267
A61B 1/303
A61B 1/307
A61B 1/313
A61B 1/24
A61B 1/247
A61B 3/12
A61B 5/0205
A61B 5/103
A61B 5/11
A61B 5/107
A61B 3/117
H04N 1/32
A61B 3/14
G06F 21/62
H04L 9/06

Abstract:

The unobtrusive health-monitoring apparatus includes a camera, a controller, a data transmission port, and, optionally, a graphics processing unit (“GPU”) which executes nonlinear transformation algorithms. The camera may be inconspicuously disposed within a fixture in the room. The camera collects graphic data which may include still images or video of the user, or both. The GPU may execute the nonlinear transformation algorithms which may transform the graphic data into formats which cannot be recognized by humans. However, these formats preserve features that can be parsed by machine learning methods and used for health tracking purposes. The formats cannot be parsed by humans or be converted back to the original image or video by mathematical inversion or available computational methods. User privacy is thus preserved. The graphic data may be transmitted to a remote processor. The remote processor may perform algorithms which create a health status analyses.

US Patent:

20200297310, Sep 24, 2020

Filed:

Mar 21, 2019

Appl. No.:

16/360708

Inventors:

David R. Hall - Provo UT, US
K. Jeffrey Campbell - Spanish Fork UT, US
Joshua Larsen - Spanish Fork UT, US
Jared Reynolds - Pleasant Grove UT, US
Daniel Hendricks - Provo UT, US
Travis Niederhauser - Mapleton UT, US
Steven J.M. Butala - Provo UT, US
Joshua D. Heiner - Lehi UT, US
A. Terrece Pearman - Draper UT, US
Vivek Garg - Sandy UT, US

International Classification:

A61B 8/00
A61B 5/00

Abstract:

The medical toilet may include a seat, lid, and bowl as does a traditional toilet. It also includes one or more acoustic transducers. The acoustic transducers may be located on the seat where they may measure bone density in a user's pelvis or femur. The acoustic transducers may be located on the lid or on a belt which wraps around the user. These acoustic transducers may collect data relating to a user's heart, lungs, liver, bowel, or other internal organs. The medical toilet may include a handrail with an acoustic transducer which measures the bone density in the user's wrist, radius, or ulna. A controller associated with the medical toilet may store algorithms for analyzing the data collected by the acoustic transducers. The controller may perform machine learning to improve the analyses and may calculate trends in repeated measurements taken from the same user or a population of users.

US Patent:

20200253480, Aug 13, 2020

Filed:

Feb 11, 2019

Appl. No.:

16/272206

Inventors:

David R. Hall - Provo UT, US
Joshua Larsen - Spanish Fork UT, US
Jared Reynolds - Pleasant Grove UT, US
Daniel Hendricks - Provo UT, US
Travis Niederhauser - Mapleton UT, US
K. Jeffrey Campbell - Spanish Fork UT, US
Steven J.M. Butala - Provo UT, US
Vivek Garg - Murray UT, US

International Classification:

A61B 5/00
G01L 1/26
A47K 13/24

Abstract:

The sensor platform array includes a plurality of sensors and one or more sensor platforms. Each sensor may be mounted on a sensor platform. The sensor platform may be mounted on a support panel. The support panel may be mounted on a toilet lid. The one or more sensor platforms may be extendable towards a user seated on the toilet. Each sensor may be independently extended so that it is positioned flush against a user's body. The sensor platform array may include bendable arms which reach around a user and place sensors on the ventral side of the user. The sensors may collect measurements which are relevant to the user's health and well-being. In some embodiments, the sensors may be removable and replaceable so that different sensors may be added according to a user's individual needs.

US Patent:

20190203454, Jul 4, 2019

Filed:

Jan 4, 2018

Appl. No.:

15/862091

Inventors:

David R. Hall - Provo UT, US
Travis Niederhauser - Mapleton UT, US
Jared Reynolds - Pleasant Grove UT, US
Joshua Larsen - Spanish Fork UT, US
Ben Swenson - Lehi UT, US
Clayton Jorgensen - Bountiful UT, US
Andrew Nguyen - Provo UT, US
Terrece Pearman - Draper UT, US
Daniel Hendricks - Provo UT, US

International Classification:

E03D 9/08
E03C 1/05
G06K 9/00
G05D 3/12

Abstract:

The bidet system may include multiple seat scales which may float between the toilet bowl rim and the toilet seat. These seat scales may collect measurements which are transmitted to a controller. The controller may include instructions to calculate a user's center of mass based on the measurements and to identify the position of the user's anus based on the center of mass. The controller may then transmit instructions to a bidet wand directing direct the bidet wand to a position which aims a cleansing fluid spray toward the user's anus. A camera which collects images of the user's anal and urogenital region may also be included in the bidet system. The camera may transmit obfuscated images to the controller to identify other areas of the user's anatomy in need of cleansing. The controller may direct the bidet wand to aim a cleansing fluid spray toward these areas.

US Patent:

20180334669, Nov 22, 2018

Filed:

May 17, 2017

Appl. No.:

15/597633

Inventors:

David R. Hall - Provo UT, US
Steven J.M. Butala - Provo UT, US
Dan Allen - Springville UT, US
Andrew Nguyen - Provo UT, US
Conrad Rosenbrock - Provo UT, US
Ben Swenson - Lehi UT, US
Daniel Hendricks - Provo UT, US
Joe Fox - Spanish Fork UT, US

International Classification:

C12N 15/10

Abstract:

We disclose a method of tagging a variety of pharmaceutical or nutritional products in which well-studied chemicals may be added to the products in unique ratios. The identities of the chemicals and their relative ratios comprise unique taggants. The taggants may identify which of multiple distinct categories the product falls within. The method includes the step of systematically varying the relative concentrations of the chemicals resulting in multiple ratios of the chemicals. The plurality of ratios of a defined set of chemicals may be collected to form a library of taggants associated with specified items or categories. As the number of chemicals added per product increases, the library supports more categories and the system is less likely to produce a false positive. The method may result in a series of taggants for each item which is single fault tolerant or double fault tolerant.

US Patent:

20180335427, Nov 22, 2018

Filed:

May 22, 2017

Appl. No.:

15/601532

Inventors:

David R. Hall - Provo UT, US
Steven J.M. Butala - Provo UT, US
Dan Allen - Springville UT, US
Andrew Nguyen - Provo UT, US
Conrad Rosenbrock - Provo UT, US
Ben Swenson - Lehi UT, US
Daniel Hendricks - Provo UT, US
Travis Niederhauser - Mapleton UT, US
Terrece Pearman - Draper UT, US
Joe Fox - Spanish Fork UT, US

International Classification:

G01N 33/543
C12Q 1/68
G01N 33/94

Abstract:

We disclose a tag for tracking and identifying pharmaceutical and nutritional products. The tag includes a paramagnetic microparticle which is connected to at least one unique and detectable chemical. The chemical may be coated on the paramagnetic microparticle or connected through functional groups. The tags may be too large to be taken into the bloodstream and therefore remain in the user's gastrointestinal tract. The tags may be fully or partially isolated from feces for analysis. The tags are attracted to an external electromagnetic force but are not magnetically attracted to each other. Consequently, the tags are safe to ingest. The tags may vary in volume or mass so as to be separable according to mass. The tags may be non-spherical in shape thus increasing the surface area to volume ratio and increasing the amount of chemical which may be attached as a taggant.

US Patent:

20180321218, Nov 8, 2018

Filed:

May 8, 2017

Appl. No.:

15/589403

Inventors:

David R. Hall - Provo UT, US
Dan Allen - Springville UT, US
Conrad Rosenbrock - Provo UT, US
Daniel Hendricks - Provo UT, US
Andrew Nguyen - Provo UT, US
Steven J.M. Butala - Provo UT, US
Travis Niederhauser - Mapleton UT, US
Terrece Pearman - Draper UT, US
Joe Fox - Spanish Fork UT, US

International Classification:

G01N 33/493
G01N 33/53
G01N 33/487
G01N 33/543
G01N 33/542
G01N 27/327
G01N 21/64
G01N 21/78
A61B 5/00
A61B 5/20

Abstract:

We disclose an in-toilet urinalysis system which includes a system for collection urine and for analysis of urine components using aptamer technology. Urine collection system may dispense urine into cuvettes, channels, or other containers that include aptamers. The aptamers may detect target molecules in urine. The aptamers may measure urine analytes, detect excreted drugs or drug metabolites, or disease markers. Upon binding to the target molecule, the aptamers may produce a signal which a sensor in the toilet may detect. In some embodiments, the signal may be electrochemical, fluorescent, or colorimetric. The measurements obtained from analysis of the urine may be used to assess a user's health or diagnose disease. In some embodiments, the measurements are stored in a controller which may transmit the measurements to a healthcare provider for assessment.

US Patent:

20180313805, Nov 1, 2018

Filed:

Apr 26, 2017

Appl. No.:

15/497501

Inventors:

David R. Hall - Provo UT, US
Dan Allen - Springville UT, US
Conrad Rosenbrock - Provo UT, US
Daniel Hendricks - Provo UT, US
Andrew Nguyen - Provo UT, US
Steven J.M. Butala - Provo UT, US
Travis Niederhauser - Mapleton UT, US
Joe Fox - Spanish Fork UT, US
Terrece Pearman - Draper UT, US

International Classification:

G01N 33/15
G01N 17/00

Abstract:

We disclose a method of using taggants to assess how and to what extent a drug in a drug composition has decayed in response to environmental conditions and time. The taggants may decay in response to environmental conditions which cause drugs to lose their efficacy. The decay may occur due to improper storage or excursions into certain environmental conditions. These environmental conditions may include light, temperature, moisture, oxidation, and age. By including taggants that have different decay characteristics, the environmental condition that caused the decay may be determined. The amount of time the drug composition was exposed to the environmental condition and the amount of effective drug remaining may also be determined. The disclosed method may reduce the need for a unique assay for each drug to assess decay and determine shelf life. The disclosed method may also be used as a quality control technique for pharmaceutical products.